Aura Biosciences (AURA)

• Market cap: $725M
• 1 day: -1.41%
• 5 days: -1.27%
• 1 month: -1.27%
• 3 months: -0.57%
• 6 months: 19.22%
• Year to date: 32.26%
• 1 year: 1.74%
• 5 years: -52.64%
• 10 years: -52.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Employees: 113